AGRX - Agile Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development9,77714,42820,92925,622
Selling General and Administrative8,73912,3838,7927,467
Non Recurring----
Others----
Total Operating Expenses18,51626,81129,72133,089
Operating Income or Loss-18,516-26,811-29,721-33,089
Income from Continuing Operations
Total Other Income/Expenses Net-1,740-1,493-2,095-3,218
Earnings Before Interest and Taxes-18,516-26,811-29,721-33,089
Interest Expense-1,116-1,918-2,446-2,077
Income Before Tax-20,256-28,304-31,816-36,307
Income Tax Expense-477--3,075-5,972
Minority Interest----
Net Income From Continuing Ops-19,779-28,304-28,741-30,335
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-19,779-28,304-28,741-30,335
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-19,779-28,304-28,741-30,335